CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
94 hedge funds and large institutions have $1.69B invested in China Biologic Products Holdings, Inc. in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
-25
Holders Change %
-21.01%
% of All Funds
2.35%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.05%
New
20
Increased
39
Reduced
29
Closed
43
Calls
$2.61M
Puts
$2.74M
Net Calls
-$127K
Net Calls Change
-$50.2M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.3M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$43.1M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$25.8M |
| 4 |
CGI
Comgest Global Investors
Paris,
France
|
+$18.9M |
| 5 |
NSRI
New Silk Road Investment
Singapore
|
+$17.5M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$88M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$78.9M |
| 3 |
BlackRock
New York
|
-$64.7M |
| 4 |
ICP
Indus Capital Partners
New York
|
-$31.5M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$25.5M |
